Could combating vitamin D deficiency reduce the incidence of autoimmune disease?

Expert Review of Clinical Immunology

Volumn 7, Issue 3, 2011, Pages 255-257

  Kinder, Brent W ^a   Hagaman, Jared T ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

autoimmune disease; connective tissue disease; prevention; treatment; vitamin D

Indexed keywords

AUTOANTIBODY; CALCITRIOL; VITAMIN D;

APOPTOSIS; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL PROLIFERATION; CLINICAL PRACTICE; CONNECTIVE TISSUE DISEASE; EDITORIAL; EVIDENCE BASED PRACTICE; HUMAN; MORBIDITY; RHEUMATOID ARTHRITIS; VITAMIN D DEFICIENCY;

AUTOIMMUNE DISEASES; CONNECTIVE TISSUE DISEASES; HUMANS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 79957511446     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.11.12     Document Type: Editorial

References (20)

1. Holick MF. Vitamin D deficiency. N. Engl. J. Med. 357(3), 266-281 (2007).
2. van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J. Steroid Biochem. Mol. Biol. 97(1-2), 93-101 (2005).
3. Baeke F, van Etten E, Gysemans C et al. Vitamin D signaling in immune-mediated disorders: evolving insights and therapeutic opportunities. Mol. Aspects Med. 29(6), 376-387 (2008).
4. Daniel C, Sartory NA, Zahn N et al. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J. Pharmacol. Exp. Ther. 324(1), 23-33 (2008). (Pubitemid 350294165)
5. Bouillon R, Carmeliet G, Verlinden L et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 29(6), 726-776 (2008).
6. Chen S, Sims GP, Chen XX et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol. 179(3), 1634-1647 (2007).
7. Lemire JM, Ince A, Takashima M. 1,25-dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity 12(2), 143-148 (1992).
8. Cantorna MT, Hayes CE, DeLuca HF. 1,25-dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J. Nutr. 128(1), 68-72 (1998). (Pubitemid 28087178)
9. Zella JB, McCary LC, DeLuca HF. Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch. Biochem. Biophys. 417(1), 77-80 (2003). (Pubitemid 36960051)
10. Cantorna MT, Munsick C, Bemiss C et al. 1,25-dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J. Nutr. 130(11), 2648-2652 (2000).
11. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann. Rheum. Dis. 66(9), 1137-1142 (2007). (Pubitemid 47309727)
12. Huisman AM, White KP, Algra A et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J. Rheumatol. 28(11), 2535-2539 (2001). (Pubitemid 33031987)
13. Kamen DL, Cooper GS, Bouali H et al. Vitamin D defsystemic lupus erythematosus. Autoimmun. Rev. 5(2), 114-117 (2006).
14. Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol. 9(6), 599-612 (2010).
15. Becker A, Fischer R, Schneider M. Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus. Z. Rheumatol. 60(5), 352-358 (2001). (Pubitemid 33701886)
16. Zold E, Szodoray P, Gaal J et al. Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res. Ther. 10(5), R123 (2008).
17. Merlino LA, Curtis J, Mikuls TR et al. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum. 50(1), 72-77 (2004). (Pubitemid 38084289)
18. Haque UJ, Bartlett SJ. Relationships among vitamin D, disease activity, pain and disability in rheumatoid arthritis. Clin. Exp. Rheumatol. 28(5), 745-747 (2010).
19. Zhou C, Assem M, Tay JC et al. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J. Clin. Invest. 116(6), 1703-1712 (2006).
20. Hagaman JT, Panos RJ, McCormack FX et al. Vitamin D deficiency and reduced lung function in connective tissue-associated interstitial lung diseases. Chest 139(2), 353-360 (2011).